Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARVCF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC00908 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
HRASLS5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRID2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCNN1D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJC21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP32P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNBD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASL12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC286238 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HELQ - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBLL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on